Clinical trials
Enrolling by invitation trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 19 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Egas Moniz - Cooperativa de Ensino Superior, CRL | 5 |
| Centro Hospitalar de Lisboa Central | 3 |
| Maria Paço | 2 |
| Novo Nordisk A/S | 2 |
| QED Therapeutics, a BridgeBio company | 2 |
| Universidade do Porto | 2 |
| Viatris Innovation GmbH | 2 |
| Academisch Ziekenhuis Maastricht | 1 |
| Alnylam Pharmaceuticals | 1 |
| Ascendis Pharma Growth Disorders A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 3 |
| Dwarfism | 3 |
| Epilepsy | 3 |
| Premature Birth | 3 |
| Seizures | 3 |
| Amyloidosis | 2 |
| Bone Diseases | 2 |
| Cardiovascular Diseases | 2 |
| Connective Tissue Diseases | 2 |
| Dermatomyositis | 2 |
Trials
Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.